Soudaflex 40FC

Hazard statements (CLP)

H334

Code

Statements

H334

May cause allergy or asthma symptoms or breathing difficulties if inhaled

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

No additional information available

2.2 Label elements

Labelling

Hazard pictograms

GHS08

Signal word

Danger

Contains

maleic anhydride; 4,4'-methylenediphenyl diisocyanate; fatty acids, C14-18 and C16-18- unsaturated, maleated; reaction mass of bis(1,2,2,6,6-pentamethyl-4-piperidyl) sebacate and methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate

Hazard statements

H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P261 - Avoid breathing vapours, mist. P284 - In case of inadequate ventilation wear respiratory protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER, a doctor. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Supplemental label elements

EUH212 - Warning! Hazardous respirable dust may be formed when used. Do not breathe dust. (Except for black/brown/transparent product).

Additional information

Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used. As from 24 August 2023 adequate training is required before industrial or professional use.

2.3 Other hazards

The product does not meet the PBT and vPvB classification criteria Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component 4,4'-methylenediphenyl diisocyanate (101-68-8) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII fatty acids, C14-18 and C16-18-unsaturated, maleated (85711-46-2) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %